McKinsey's China Healthcare Summit Report
Download This Exclusive Report
What are the latest trends shaping the biopharma industry in China? The exclusive Building Bridges to Innovation report by McKinsey & Co. was commissioned for the 5th BioCentury-BayHelix China Healthcare Summit (Nov. 13-14, 2018, Shanghai). Based on a survey of industry leaders, the report discusses:
- Will quality and reimbursement reforms create a “year of reckoning” for mature brands in China?
- How fast is market access improving in China for innovative products?
- Has the war for talent in China reached a boiling point?
- Can local biopharma innovation compete with multinational products in China?
- How will digitization improve physician and patient engagement in China?
- Plus: The third edition of McKinsey's China Drug Innovation Index (CDII)
We invite you to download a complimentary copy.
The BioCentury-BayHelix China Healthcare Summit is an annual event organized by BioCentury and BayHelix in collaboration with McKinsey & Co. This year's conference saw record attendance. We hope to see you in 2019! For sponsorship inquiries, please contact firstname.lastname@example.org.
Executive Director & Editor, New Ventures